Neoadjuvant anti–programmed cell death 1 therapy for locally advanced basal cell carcinoma in treatment-naive patients: A case series

• Katherine Given Ligtenberg, MD, PhD, MBA,
• Jamie Katy Hu, BA,
• William Damsky, MD, PhD,
• Kelly Olino, MD,
• Harriet Kluger, MD,
• James Clune, MD,
• Shawn E. Cowper, MD,
• Gauri Panse, MD,
• Jonathan Leventhal, MD,
• Sarah A. Weiss, MD

Affiliations

Katherine Given Ligtenberg, MD, PhD, MBA

Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut

Jamie Katy Hu, BA

Yale University School of Medicine, New Haven, Connecticut

William Damsky, MD, PhD

Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut

Kelly Olino, MD

Department of Surgery, Yale University School of Medicine, New Haven, Connecticut

Harriet Kluger, MD

Department of Medicine/Medical Oncology, Yale University School of Medicine, New Haven, Connecticut

James Clune, MD

Department of Plastic and Reconstructive Surgery, Yale University School of Medicine, New Haven, Connecticut

Shawn E. Cowper, MD

Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut

Gauri Panse, MD

Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut

Jonathan Leventhal, MD

Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut

Sarah A. Weiss, MD

Department of Medicine/Medical Oncology, Yale University School of Medicine, New Haven, Connecticut; Correspondence to: Sarah A. Weiss, MD, Yale Cancer Center, 333 Cedar St, New Haven, CT 06520.